Login / Signup

Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A.

Jie GongRui YangMin ZhouLung-Ji Chang
Published in: Molecular medicine (Cambridge, Mass.) (2023)
mice, thus has a great potential for clinical applications.
Keyphrases
  • gene therapy
  • poor prognosis
  • dna methylation
  • high fat diet induced
  • endothelial cells
  • gene expression
  • transcription factor
  • high dose
  • binding protein
  • human health
  • long non coding rna
  • low dose
  • metabolic syndrome